The Fate of Patients With Clinical Recurrence After Sirolimus-Eluting Stent Implantation (a Two-Year Follow-Up Analysis from the SIRIUS Trial)

American Journal of Cardiology

Volumn 97, Issue 11, 2006, Pages 1582-1584

  Moussa, Issam D ^a   Moses, Jeffrey W ^a   Kuntz, Richard E ^c   Holmes, David R ^d   Popma, Jeffrey J ^c   Teirstein, Paul S ^e   Wong, S Chiu ^b   Leon, Martin B ^a  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^b WEILL CORNELL MEDICAL CENTER   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d MAYO CLINIC   (United States)

^e SCRIPPS CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RAPAMYCIN;

ADULT; AGED; ARTICLE; BALLOON DILATATION; BRACHYTHERAPY; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART MUSCLE ISCHEMIA; HUMAN; MALE; PRIORITY JOURNAL; RECURRENT DISEASE; RESTENOSIS; REVASCULARIZATION;

BLOOD VESSEL PROSTHESIS IMPLANTATION; COATED MATERIALS, BIOCOMPATIBLE; CORONARY RESTENOSIS; CORONARY STENOSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; SIROLIMUS; STENTS; SURVIVAL RATE; TREATMENT FAILURE;

EID: 33646701224     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2005.12.048     Document Type: Article

References (6)

1. Morice M.C., Serruys P.W., Sousa J.E., Fajadet J., Ban Hayashi E., Perin M., Colombo A., Schuler G., Barragan P., Guagliumi G., et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 346 (2002) 1773-1780
2. Moses J.W., Leon M.B., Popma J.J., Fitzgerald P.J., Holmes D.R., O'Shaughnessy C., Caputo R.P., Kereiakes D.J., Williams D.O., Teirstein P.S., et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349 (2003) 1315-1323
3. Schofer J., Schluter M., Gershlick A.H., Wijns W., Garcia E., Schampert E., Breithhardt, and E.-S.I.R.I.U.S. Investigators. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries. double-blind, randomised controlled trial (E-SIRIUS). Lancet 362 (2003) 1093-1099
4. Lemos P.A., van Mieghem C.A.G., Arampatzis C.A., Hoye A., Ong A.T.L., McFadden E., Sianos G., van der Giessen W.J., de Feyter P.J., van Domburg R.T., and Serruys P.W. Post-sirolimus-eluting stent restenosis treated with repeat percutaneous intervention. late angiographic and clinical outcomes. Circulation 109 (2004) 2500-2502
5. Melzi G., Cosgrave J., Biondi-Zoccai G., Chieffo A., Airoldi F., Iakovou I., Sangiorgi G., Michev I., Montorfano M., and Colombo A. Focal sirolimus-eluting stent restenosis. an emerging problem. Am J Cardiol 96 suppl (2005) TCT-483
6. Holmes DR, Leon MB, Moses JW, Popma JJ, Cutlip D, Fitzgerald PJ, Brown C, Fischell T, Wong SC, Midei M, Snead D, Kuntz RE. Analysis of 1-year clinical outcomes in the SIRIUS trial. A randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosis.